Kyowa Hakko Kirin is a pharmaceutical company mainly engaged in medical product and biochemical businesses. Co. operates in two business segments: medical product, and biochemical. Co. is engaged in the manufacture, sale and sales promotion of medical products for hospital use, the development of candidate substances for new drugs, the provision of technologies for antibody drug creation; the manufacture and sale of medical and industrial materials, mainly amino and nucleic acids, and health care products; the design and construction of facilities; the distribution, insurance agency and wholesale businesses.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.